The emergence of Retatrutide ZPHC, at a concentration of 120mg, is generating considerable excitement within the weight loss community. This groundbreaking dual GIP and GLP-1 receptor medication appears to deliver notable improvements in fat reduction compared to current therapies. Initial resear